Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001685619-22-000003
Filing Date
2022-04-06
Accepted
2022-04-06 15:47:55
Documents
1
Effectiveness Date
2022-04-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8383
  Complete submission text file 0001685619-22-000003.txt   9480
Mailing Address 101 AVENUE OF THE AMERICAS FLOOR 3 (C/O JLABS) NEW YORK NY 10013
Business Address 101 AVENUE OF THE AMERICAS FLOOR 3 (C/O JLABS) NEW YORK NY 10013 646-640-7865
Acuamark Diagnostics, Inc. (Filer) CIK: 0001685619 (see all company filings)

EIN.: 461181186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-440683 | Film No.: 22810506